Invitae (NYSE:NVTA – Get Rating) and Biodesix (NASDAQ:BDSX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership. Insider and Institutional Ownership 76.8% of Invitae shares are owned by […]
Invitae Co. (NYSE:NVTA – Get Rating) has earned a consensus recommendation of “Hold” from the twelve analysts that are covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average 12 month price objective among analysts that have […]
Shares of Invitae Co. (NYSE:NVTA – Get Rating) have been assigned an average recommendation of “Hold” from the twelve research firms that are covering the company, MarketBeat.com reports. Five analysts have rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average 1 year price target among […]
Shares of Invitae Co. (NYSE:NVTA – Get Rating) have earned an average rating of “Hold” from the twelve analysts that are currently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average twelve-month price target among […]